Exon Biosystems

Fate Therapeutics, Inc, based in San Diego, CA, is a biotechnology company dedicated to transforming the lives of patients with cancer and autoimmune disorders through innovative cellular therapy. With a focus on developing novel product candidates like FT576, FT522, FT819, and FT825, Fate Therapeutics aims to harness the power of iPSC technology to create personalized treatments. Driven by a mission to deliver cutting-edge solutions, Fate Therapeutics boasts a robust pipeline, a talented management team, and a commitment to corporate responsibility. Through their pioneering work in science, manufacturing, and collaborations, the company continues to pave the way for advancements in the field of cellular therapy.Generated from the website

Cholestech provides diagnostic tools and information to health care practitioners in more than 35 countries worldwide. It offers diagnostic testing for cholesterol, lipids, blood glucose, liver enzymes and glycemic control. The company also provides risk assessment and therapeutic monitoring solutions for heart disease and diabetes. Its products, Cholestech LDX and Cholestech GDX systems, are approved by the Food & Drug Administration (FDA) to be used for monitoring the progress of patient therapy. Its Cholestech GDX system, a hemoglobin A1C testing system is comprised of GDX analyzer, single-use test cartridges and related accessories that indicate blood sugar control over last two and three months. Cholestech sells products throughout the United States, as well as Europe, Asia, South America and Australia through a network of distributors.

Contact CalciMedica in La Jolla, CA, to learn more about our biotech company focused on compounds that modulate intracellular calcium via CRAC channels.